The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Due to the higher than anticipated C-77H re-frac costs caused by a global shortage of fraccing services and equipment, and the delayed start up of gas production on the Cambay field, Oilex plans to raise additional funds over the next approximate month.
first time able to sell my 2 million shares in one go. What the fcku does that mean?
Expecting a volatile week with such a high volume of shares traded last Friday. Can see the MMS short at times, and if there is a buyer/seller then expect lots of volatility. Who knows it might delist but it won't be for a few weeks so its going to be an interesting few weeks. 4m map for some something that started over 200 million. Way oversold at the moment
Billion dollar potential here. Should see 100% here today
Billion dollar potential here. Should see 100% here today
The Genedrive(R) HCV -ID Kit allows for decentralised molecular testing of Hepatitis C (HCV) by PCR, providing results within 90 minutes direct from a small plasma sample (30 ul). This allows for testing to be done outside of a large hospital facility and indeed while a patient may be waiting for a result. The assay is performed on the Genedrive(R) platform, the only truly portable molecular diagnostics system designed for diagnosing HCV at the point of need.